2024-11-01 2025-10-31 false Capium Accounts Production 1.1 12030331 2024-11-01 2025-10-31 12030331 bus:AbridgedAccounts 2024-11-01 2025-10-31 12030331 bus:FRS102 2024-11-01 2025-10-31 12030331 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 12030331 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 12030331 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12030331 2024-11-01 2025-10-31 12030331 2025-10-31 12030331 bus:RegisteredOffice 2024-11-01 2025-10-31 12030331 core:WithinOneYear 2025-10-31 12030331 core:AfterOneYear 2025-10-31 12030331 1 2024-11-01 2025-10-31 12030331 bus:Director1 2024-11-01 2025-10-31 12030331 bus:Director1 2025-10-31 12030331 bus:Director1 2023-11-01 2024-10-31 12030331 2023-11-01 12030331 bus:LeadAgentIfApplicable 2024-11-01 2025-10-31 12030331 2023-11-01 2024-10-31 12030331 2024-10-31 12030331 core:WithinOneYear 2024-10-31 12030331 core:AfterOneYear 2024-10-31 12030331 bus:EntityAccountantsOrAuditors 2023-11-01 2024-10-31 12030331 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 12030331 bus:OrdinaryShareClass1 2025-10-31 12030331 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 12030331 bus:OrdinaryShareClass1 2024-10-31 12030331 core:PlantMachinery 2024-11-01 2025-10-31 12030331 core:PlantMachinery 2025-10-31 12030331 core:PlantMachinery 2024-10-31 12030331 core:MotorCars 2024-11-01 2025-10-31 12030331 core:MotorCars 2025-10-31 12030331 core:MotorCars 2024-10-31 12030331 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-10-31 12030331 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-10-31 12030331 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 12030331 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 12030331 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 12030331 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 12030331 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 12030331 core:Non-currentFinancialInstruments 2025-10-31 12030331 core:Non-currentFinancialInstruments 2024-10-31 12030331 core:ShareCapital 2025-10-31 12030331 core:ShareCapital 2024-10-31 12030331 core:RetainedEarningsAccumulatedLosses 2025-10-31 12030331 core:RetainedEarningsAccumulatedLosses 2024-10-31 12030331 dpl:Item1 2024-11-01 12030331 dpl:Item1 2025-10-31 12030331 dpl:Item1 2023-11-01 12030331 dpl:Item1 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12030331
England and Wales

 

 

 

INJECTION SPECIALIST LTD



Abridged Accounts
 


Period of accounts

Start date: 01 November 2024

End date: 31 October 2025

Injection Specialist Ltd
Contents Page
For the year ended 31 October 2025
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of Injection Specialist Ltd for the year ended 31 October 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Injection Specialist Ltd for the year ended 31 October 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the companys accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance
This report is made solely to the Board of Directors of Injection Specialist Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Injection Specialist Ltd and state those matters that we have agreed to state to the Board of Directors of Injection Specialist Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Injection Specialist Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Injection Specialist Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Injection Specialist Ltd. You consider that Injection Specialist Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Injection Specialist Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts 31 October 2025



....................................................

FDCA Limited
Office 2 Bennet's House
21 Leyton Road
Harpenden
AL5 2HU
29 July 2026
1
 
 		 Notes
 		 31/10/2025
£		   31/10/2024
£
Fixed assets      
Tangible fixed assets 3 7,356    11,357 
7,356    11,357 
Current assets      
Stocks 15,000    15,000 
Debtors 8,871    3,462 
Cash at bank and in hand 9,354    5,741 
33,225    24,203 
Creditors: amount falling due within one year (112,896)   (43,422)
Net current assets (79,671)   (19,219)
 
Total assets less current liabilities (72,315)   (7,862)
Creditors: amount falling due after more than one year (2,923)   (67,417)
Net assets (75,238)   (75,279)
 

Capital and reserves 		     
Called up share capital 4 100    100 
Profit and loss account (75,338)   (75,379)
Shareholders' funds (75,238)   (75,279)
 


For the year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 July 2026 and were signed by:


-------------------------------
Nadir Tuna
Director
2
General Information
Injection Specialist Ltd is a private company, limited by shares, registered in England and Wales, registration number 12030331, registration address 49 Plover Crescent, Harlow, CM17 0RZ. The trading address of the company is Unit 20 Redbridge Enterprise Centre, Ilford, IG1 1TY.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared under the historical cost convention and in accordance with FRS 102 Section 1A and the Companies Act 2006. The financial statements are presented in sterling, which is the companys functional and presentation currency.
Turnover
Revenue from repair and testing services is recognised when the service has been performed and the customer has accepted the work. Revenue from the sale of parts and other goods is recognised when control of the goods passes to the customer, normally on delivery or collection. Revenue is measured net of VAT, discounts, returns and allowances.
Website cost
Planning and operating costs for the company's website are charged to the income statement as incurred.
Taxation
Current tax is based on taxable profit for the period using rates enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of timing differences. Deferred tax assets, including those arising from tax losses, are recognised only to the extent that recovery against future taxable profits or reversing deferred tax liabilities is probable. Deferred tax balances are not discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and impairment. Depreciation is charged to write off cost, less estimated residual value, over the expected useful lives of the assets as follows: plant and machinery 20% per annum straight line; motor vehicles 18% per annum reducing balance. Useful lives, residual values and indicators of impairment are reviewed at each reporting date.
Plant and Machinery 5 Years Straight Line
Motor Vehicles 18% Reducing Balance
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises the purchase price and directly attributable conversion costs and is determined using the first-in, first-out method. Provision is made for obsolete, damaged and slow-moving items.
Financial instruments
Basic financial assets and liabilities are initially measured at transaction price and subsequently measured at amortised cost. Trade debtors are stated after provision for impairment. Financial liabilities are classified as current where they are due, or the company does not have an unconditional right at the reporting date to defer settlement, for at least twelve months.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Motor Vehicles   Total
  £   £   £
At 01 November 2024 14,920    9,750    24,670 
Additions -    -    - 
Disposals -    -    - 
At 31 October 2025 14,920    9,750    24,670 
Depreciation
At 01 November 2024 9,214    4,099    13,313 
Charge for year 2,984    1,017    4,001 
On disposals -    -    - 
At 31 October 2025 12,198    5,116    17,314 
Net book values
Closing balance as at 31 October 2025 2,722    4,634    7,356 
Opening balance as at 01 November 2024 5,706    5,651    11,357 


4.

Share Capital

Authorised
100 Ordinary shares of £1.00 each
Allotted, called up and fully paid
31/10/2025
£		   31/10/2024
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

3